Our News
Discover the latest news from the Transformative Rare Cancer Initiative
Showcasing new strides in rare cancer research
Local and national experts in areas such as immunotherapy, clinical trial design and biobanking gathered to spotlight breakthroughs in rare cancer research.
Are Tissue-Agnostic Oncology Drugs a Silver Bullet for Rare Cancers?
TRACER’s director shares how treatments guided by tumor biology — not location — could reshape care for patients with rare cancers.
Fred Hutch study finds new life for ‘ineffective’ drugs
Testing drugs on thin tumor slices, not just cancer cells in a Petri dish, reveals untapped potential for treating rare cancers.
A new partnership aims to advance rare cancer research — with patients’ help
A coast-to-coast collaboration between TRACER and RCRF aims to turn patient-donated tumors into AI-powered insights on rare cancers.
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium.
Oncologists Turn to Off-Label Drug Use for Rare Cancers: What to Know
TRACER’s director explains why off-label prescribing — guided by tumor biology — is becoming a vital and proactive strategy for rare cancers.